Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors, or statins, lower total cholesterol, low-density lipoprotein (LDL), and triglyceride concentrations while increasing high-density lipoprotein (HDL) concentrations. FDA-approved statins include atorvastatin, rosuvastatin, simvastatin, pravastatin, fluvastatin, lovastatin and pitavastatin.

The FDA-approved indications for statins are:

- Hyperlipidemia and mixed dyslipidemia

- Primary dysbetalipoproteinemia (Type III hyperlipoproteinemia)

- Hypertriglyceridemia

- Atherosclerosis

- Primary prevention ofÂ ASCVD (atherosclerotic cardiovascular disease)

- Secondary prevention in patients with clinical ASCVD

- Pediatric patients with familial hypercholesterolemia

- Adult patients with homozygous familial hypercholesterolemia